Tyra Biosciences shares jump on next week Phase 2 readout
Tyra Biosciences said initial clinical results from a key Phase 2 bladder cancer study will be announced next week. Shares were up more than 15% at the time of writing.
Tyra Biosciences (TYRA) was on investors’ radar after the biotech company said the initial clinical results from a key Phase 2 study of its experimental bladder cancer treatment will be announced next week.At the time of writing, TYRA stock was up more than 15% and is on track to clock its biggest…